BRPI0919816A2 - uso compostos benzoxazólicos no tratamento de malária - Google Patents

uso compostos benzoxazólicos no tratamento de malária

Info

Publication number
BRPI0919816A2
BRPI0919816A2 BRPI0919816A BRPI0919816A BRPI0919816A2 BR PI0919816 A2 BRPI0919816 A2 BR PI0919816A2 BR PI0919816 A BRPI0919816 A BR PI0919816A BR PI0919816 A BRPI0919816 A BR PI0919816A BR PI0919816 A2 BRPI0919816 A2 BR PI0919816A2
Authority
BR
Brazil
Prior art keywords
malaria
treatment
benzoxazole compounds
benzoxazole
compounds
Prior art date
Application number
BRPI0919816A
Other languages
English (en)
Inventor
Gusovsk Fabian
Spyvee Mark
Tostes Gazinelli Ricardo
t ishizaka Sally
Zheng Wanjun
Original Assignee
Eisai R&D Man Co Ltd
Univ Minas Gerais
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd, Univ Minas Gerais filed Critical Eisai R&D Man Co Ltd
Publication of BRPI0919816A2 publication Critical patent/BRPI0919816A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0919816A 2008-09-26 2009-09-25 uso compostos benzoxazólicos no tratamento de malária BRPI0919816A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10068308P 2008-09-26 2008-09-26
US16839109P 2009-04-10 2009-04-10
US23850609P 2009-08-31 2009-08-31
PCT/US2009/058401 WO2010036908A1 (en) 2008-09-26 2009-09-25 Use of benzoxazole compounds in the treatment of malaria

Publications (1)

Publication Number Publication Date
BRPI0919816A2 true BRPI0919816A2 (pt) 2019-09-24

Family

ID=41278834

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919816A BRPI0919816A2 (pt) 2008-09-26 2009-09-25 uso compostos benzoxazólicos no tratamento de malária

Country Status (2)

Country Link
BR (1) BRPI0919816A2 (pt)
WO (1) WO2010036908A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2661510T3 (es) * 2011-12-15 2018-04-02 Novartis Ag Uso de inhibidores de la actividad o función de PI3K
AU2017238758B2 (en) 2016-03-21 2021-01-21 Council Of Scientific & Industrial Research Blocking toll-like receptor 9 signaling with small molecule antagonist
WO2019210160A1 (en) * 2018-04-26 2019-10-31 Brandeis University Antibacterial compounds, compositions and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051821A1 (en) * 2000-12-22 2002-07-04 Astrazeneca Ab Therapeutic compounds
DE10134775A1 (de) * 2001-07-06 2003-01-30 Schering Ag 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
UA83620C2 (ru) * 2001-12-05 2008-08-11 Уайт Замещенные бензоксазолы и их аналоги как эстрогенные агенты
AR045955A1 (es) * 2003-09-30 2005-11-16 Janssen Pharmaceutica Nv Compuestos benzoimidazolicos
TW200612925A (en) * 2004-08-26 2006-05-01 Wyeth Corp Prodrug substituted benzoxazoles as estrogenic agents
FR2884516B1 (fr) * 2005-04-15 2007-06-22 Cerep Sa Antagonistes npy, preparation et utilisations
AU2006320556A1 (en) * 2005-12-01 2007-06-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Isotopically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins
JP4974905B2 (ja) * 2006-02-08 2012-07-11 株式会社静岡カフェイン工業所 サイトカイン産生阻害剤及びヘテロ環式フェノキシ誘導体

Also Published As

Publication number Publication date
WO2010036908A1 (en) 2010-04-01

Similar Documents

Publication Publication Date Title
LTC2340031I2 (lt) Gdf gaudyklės, skirtos naudoti anemijos gydymui
SMT201500206B (it) Composti spiro-ossindolici e loro uso come agenti terapeutici
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
PT3812360T (pt) Compostos de monoclorotrifluoropropeno e composições e métodos utilizando os mesmos
IL211309A (en) Binder of energized components in an ophthalmic lens
BRPI0821668A2 (pt) Uso
DK2300609T3 (da) Hidtil ukendt flagellinbaserede immunadjuvansforbindelser samt anvendelse deraf
SMT201400008B (it) Uso di betanecolo per il trattamento di xerostomia
BRPI1012533A2 (pt) composto de piradazinona e uso do mesmo
BRPI0912213A2 (pt) preparação cosmética
EP2334277A4 (en) CRUTCH
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
PL2338519T3 (pl) Środek do leczenia zwłóknienia szpiku
BRPI1007494A2 (pt) composto e uso do mesmo
EP2283756A4 (en) BASIN
EP2207567A4 (en) IMMUNOGENIC FORMULATIONS
BRPI0909223A2 (pt) uso de catepsaina c
BRPI0915905A2 (pt) uso de derivados de pirimidilaminobenzamida para o tratamento de fibrose
BRPI0909840A2 (pt) Uso de 4-tio-2-deoxinucleosídios
BRPI0907956A2 (pt) Uso de ranolazina para o tratamento de doenças cardiovasculares
HRP20160577T1 (hr) Liječenje osteoartritisa
DE602008005536D1 (de) Herstellung von MnB12H12
BRPI0909096A2 (pt) uso de conjugados de interleicna-1 no tratamento de diabetes
BRPI0822637A2 (pt) Uso de lanosta-8, 24-dien-3-óis
BRPI0811572A2 (pt) Uso de compostos imunomoduladores no tratamento de doenças alérgicas

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.6 NA RPI NO 2543 DE 01/10/2019 POR TER SIDO INDEVIDA. UMA VEZ QUE OS RECOLHIMENTOS DAS ANUIDADES FORAM EFETUADOS CORRETAMENTE.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements